Sign in
4

Changes in Ownership

Syndax Pharmaceuticals Inc Filed Acc 0001562180-17-002011

Chief Scientific Officer sold 5,000 shares at $15.00 ($75,000)

  • Chief Scientific Officer acquired 732 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Ordentlich Peter · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2017-05-17 Exercise or conversion : show line 1 in the form +732 $3.08 $2,255 5,000 D
2017-05-17 Sale : show line 2 in the form −5,000 $15.00 $75,000 0 D
Open-market sales · 5,000 sh · avg $15.00 · $75,000

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2017-05-17 Exercise or conversion : show line 3 in the form Employee Stock Option (right to buy) −732 0 D
Loading xslF345X03/primarydocument.xml…